Panahi, M., Skelly, Y., & Zaman, R. (2021). The effect of biosimilar administration on clinical outcomes in patients with adalimumab‐controlled psoriasis. Wiley.
Chicago Style (17th ed.) CitationPanahi, M., Y. Skelly, and R. Zaman. The Effect of Biosimilar Administration on Clinical Outcomes in Patients with Adalimumab‐controlled Psoriasis. Wiley, 2021.
MLA (8th ed.) CitationPanahi, M., et al. The Effect of Biosimilar Administration on Clinical Outcomes in Patients with Adalimumab‐controlled Psoriasis. Wiley, 2021.
Warning: These citations may not always be 100% accurate.